Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Surathanion Feb 15, 2022 7:19am
232 Views
Post# 34429032

Therma News is Out

Therma News is OutTherma Bright news is out on finishing the study and they are either ready or preparing report for FDA submission for EUA.

Two points:

1. News release was wishy-washy on whether report/study has been submitted yet or still being prepped. top part of release states report is being prepped for submission and bottom of report states it has been submitted....so not sure what stage THRM is at.

2. Positive samples is only at 80.03% and in my mind not that great of a result. Would have been better if it was 90% or higher and nowhere in the release does it state what it needs to be for FDA EUA.  If min requirement for FDA EUA is 80% then we just squeak by.

Let's hope this is enough to get THRM to at least $0.60.

Cheers,
<< Previous
Bullboard Posts
Next >>